IRONWOOD PHARMACEUTICALS, INC. Operating Leases, Future Minimum Payments, Due in Two Years
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Operating Leases, Future Minimum Payments, Due in Two Years of $18.31 million as of 2019-12-31, per its 10-K filed 2020-02-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-02-13
- 2019-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $18.31M.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $18.31M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $17.79M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $831.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2019-12-31 | $18.31M 10-K · filed 2020-02-13 |
| 2018-12-31 | $18.31M 10-Q · filed 2019-10-31 |
| 2017-12-31 | $17.79M 10-K · filed 2018-02-22 |
| 2016-12-31 | $831.00K 10-K · filed 2017-02-22 |
| 2016-09-30 | $20.50M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $20.50M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $20.52M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $16.17M 10-K · filed 2016-02-19 |
| 2014-12-31 | $15.62M 10-K · filed 2015-02-18 |
| 2013-12-31 | $14.15M 10-K · filed 2014-02-07 |
| 2012-12-31 | $13.07M 10-K · filed 2013-02-21 |
| 2011-12-31 | $11.65M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |